Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Publication year range
1.
Ital J Gastroenterol Hepatol ; 30(1): 91-5, 1998 Feb.
Article in English | MEDLINE | ID: mdl-9615273

ABSTRACT

BACKGROUND/AIMS: Operative endoscopy is now the method of choice for treating numerous biliary tree diseases. In the treatment of benign strictures of the biliary tree, endoscopy serves as an alternative to surgical interventions. We evaluated the efficacy of endoscopic biliary stents in the treatment of benign biliary strictures. PATIENTS: Fifty-three consecutive patients with benign strictures of the biliary tree underwent endoscopic placement of one or more 10-12 Fr endoprostheses. Thirty-nine patients (73.6%) had iatrogenic strictures and 14 had inflammatory strictures (in 8 patients due to gallstones and in 6, chronic pancreatitis). Of the 53 patients, 20 (37.7%) had strictures classified as Bismuth type I, 23 (43.3%) Bismuth type II, 7 (13.2%) Bismuth type III and 3 (5.7%) Bismuth type IV. RESULTS: None of the patients died during the study period; three patients (5.6%) had immediate endoscopy-related complications treated conservatively. Late complications developed in 47.1% of the patients: 11.3% had cholangitis amenable to medical therapy, 5.6% had dislodged endoprostheses and 30.2% had obstructed endoprostheses. The reason why blocked stents accounted for most of the long-term complications in this series was that endoprostheses were not changed electively: they were changed only when clinical and laboratory signs indicated obstruction. Follow-up (6-84 months) in 42 of the 56 patients. 20 after stent removal, showed that 71.4% had an excellent outcome, 14.3% good results and 14.3% needed surgery. CONCLUSION: In benign biliary stricture endoscopic stenting is the first approach, providing definitive treatment or preparing patients for surgery.


Subject(s)
Cholestasis/surgery , Endoscopy , Prosthesis Implantation/methods , Cholestasis/etiology , Follow-Up Studies , Humans , Postoperative Complications , Retrospective Studies , Stents , Treatment Outcome
2.
Panminerva Med ; 38(2): 121-8, 1996 Jun.
Article in English | MEDLINE | ID: mdl-8979745

ABSTRACT

Renal cell carcinoma is rare in adolescents. Observation of a 16-year-old girl with a clear-cell carcinoma prompted us to review 372 published cases in adolescents. The tumor affects the sexes indifferently and has no side predominance. The incidence is higher in white races. The most frequent presenting sign is a palpable mass (52.7%). X-ray films typically show renal calcifications (25%). The most common histotype is the clear cell carcinoma (76.8%) and at diagnosis 59.5% of these tumors already extended beyond the kidney. The overall 5-year actuarial survival rate is 60.4%.


Subject(s)
Carcinoma, Renal Cell/diagnosis , Kidney Neoplasms/diagnosis , Adolescent , Carcinoma, Renal Cell/epidemiology , Female , Humans , Incidence , Kidney Neoplasms/epidemiology , Male , Sex Distribution
3.
G Chir ; 17(5): 269-75, 1996 May.
Article in Italian | MEDLINE | ID: mdl-8755228

ABSTRACT

The Authors describe a case of double jejunal diverticulum, characterized by the presence of a leiomyosarcoma in one diverticulum and ectopic pancreatic mucosa in the other. The rarity of the occurrence of a leiomyosarcoma in the diverticular area is outlined; only few cases have been reported in Literature, excluding those originating, from Meckel's diverticulum. Barium X-rays of the small intestine allowed the neoplasia to be discovered, while an Echo-Color-Doppler examination suggested the histological type given the high vascularization typical of leiomyosarcomas.


Subject(s)
Diverticulum/complications , Jejunal Diseases/complications , Jejunal Neoplasms , Leiomyosarcoma , Female , Humans , Jejunal Neoplasms/pathology , Jejunal Neoplasms/surgery , Jejunum/pathology , Leiomyosarcoma/pathology , Leiomyosarcoma/surgery , Middle Aged
4.
Int Surg ; 77(3): 158-63, 1992.
Article in English | MEDLINE | ID: mdl-1328103

ABSTRACT

Data of 111 patients with ductal carcinoma of the pancreas examined over a decade (1979-1989) at the 1st Department of Surgery, "La Sapienza" University of Rome, are presented. 21.6% of them underwent pancreatic resection and 40.5% biliodigestive diversion. Resectability was 26.5% for tumors of the head, 11.8% for tumors of the body and tail, nil for diffuse tumors. Overall operative mortality was 13.5%. Only stage I patients were shown to be resectable for cure and benefited from surgery with 21% probability of 5-year survival.


Subject(s)
Carcinoma, Intraductal, Noninfiltrating/surgery , Pancreatic Neoplasms/surgery , Adult , Aged , Carcinoma, Intraductal, Noninfiltrating/mortality , Carcinoma, Intraductal, Noninfiltrating/pathology , Female , Humans , Male , Middle Aged , Pancreatic Neoplasms/mortality , Pancreatic Neoplasms/pathology , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...